231 related articles for article (PubMed ID: 18085520)
1. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas.
Zeng Q; Chen G; Vlantis A; Tse G; van Hasselt C
J Pathol; 2008 Mar; 214(4):425-33. PubMed ID: 18085520
[TBL] [Abstract][Full Text] [Related]
2. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway.
Zeng Q; Chen GG; Vlantis AC; van Hasselt CA
Cell Prolif; 2007 Dec; 40(6):921-35. PubMed ID: 18021179
[TBL] [Abstract][Full Text] [Related]
4. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.
Kumar A; Klinge CM; Goldstein RE
Int J Oncol; 2010 May; 36(5):1067-80. PubMed ID: 20372779
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells.
Chen JQ; Delannoy M; Cooke C; Yager JD
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E1011-22. PubMed ID: 14736707
[TBL] [Abstract][Full Text] [Related]
6. Differential distribution of glucocorticoid and estrogen receptor isoforms: localization of GRbeta and ERalpha in nucleoli and GRalpha and ERbeta in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines.
Solakidi S; Psarra AM; Sekeris CE
J Musculoskelet Neuronal Interact; 2007; 7(3):240-5. PubMed ID: 17947807
[TBL] [Abstract][Full Text] [Related]
7. The role of oestrogen receptor {alpha} in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2.
Kavanagh DO; McIlroy M; Myers E; Bane F; Crotty TB; McDermott E; Hill AD; Young LS
Endocr Relat Cancer; 2010 Mar; 17(1):255-64. PubMed ID: 20032008
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
[TBL] [Abstract][Full Text] [Related]
9. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11.
Helguero LA; Faulds MH; Gustafsson JA; Haldosén LA
Oncogene; 2005 Oct; 24(44):6605-16. PubMed ID: 16007178
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.
Monroe DG; Getz BJ; Johnsen SA; Riggs BL; Khosla S; Spelsberg TC
J Cell Biochem; 2003 Oct; 90(2):315-26. PubMed ID: 14505348
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen modulates cardiac ischaemic remodelling through oestrogen receptor-specific mechanisms.
Babiker FA; Lips DJ; Delvaux E; Zandberg P; Janssen BJ; Prinzen F; van Eys G; Grohé C; Doevendans PA
Acta Physiol (Oxf); 2007 Jan; 189(1):23-31. PubMed ID: 17280554
[TBL] [Abstract][Full Text] [Related]
15. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
16. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of mitochondrial oestrogen receptor beta and oestrogen-induced attenuation of cytochrome c oxidase subunit I expression in human periodontal ligament cells.
Jönsson D; Nilsson J; Odenlund M; Bratthall G; Broman J; Ekblad E; Lydrup ML; Nilsson BO
Arch Oral Biol; 2007 Jul; 52(7):669-76. PubMed ID: 17223066
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of Hsp27 by ERα/Sp1 facilitates proliferation and confers resistance to apoptosis in human papillary thyroid cancer cells.
Mo XM; Li L; Zhu P; Dai YJ; Zhao TT; Liao LY; Chen GG; Liu ZM
Mol Cell Endocrinol; 2016 Aug; 431():71-87. PubMed ID: 27179757
[TBL] [Abstract][Full Text] [Related]
19. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
[TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
